Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8<sup>+</sup>T cell function and its impact against pancreatic ductal adenocarcinoma.

Authors:
Wei W; Tian L; Zheng X; Zhong L; Chen Y and 4 more

Journal:
Oncoimmunology

Publication Year: 2024

DOI:
10.1080/2162402X.2024.2322173

PMCID:
PMC10900272

PMID:
38419758

Journal Information

Full Title: Oncoimmunology

Abbreviation: Oncoimmunology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure statement No potential conflict of interest was reported by the author(s)."

Evidence found in paper:

"Author contributions: WW and LT analyzed data, performed experiments, drew figures and tables, and wrote the manuscript. GZ and SW funded this study, while XZ, LZ, HD, and GZ conducted experiments and statistical analysis. XT, SW, and YC designed the study, assisted with logistics, and reviewed paper drafts. Each author approved the final manuscript after this review."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025